Mid Trimester Abortion Effectiveness by Dilapan s
Launched by AIN SHAMS MATERNITY HOSPITAL · Nov 23, 2021
Trial Information
Current as of June 06, 2025
Unknown status
Keywords
ClinConnect Summary
od complete history taking and examination will be performed including measurement of blood pressure, pulse and temperature. Skin was examined for petichae or ecchymosis to exclude coagulation defects or blood diseases. The abdominal examination included detection of the size of the uterus (in cm above symphysis pubis), presence of scar of previous laparotomy, tenderness or rigidity. The local examination included detection of uterine size by bimanual examination, cervical dilatation, consistency, effacement, and position.
Each patient was investigated for hemoglobin content, Rh-typing, bl...
Gender
FEMALE
Eligibility criteria
- Inclusion Inclusion Criteria:
- • Sure indication of abortion.
- • Estimated gestational age between 12-24 weeks as calculated from last normal menstrual period (LNMP) and confirmed by abdominal ultrasound.
- • Intact membranes.
- • No medical disorder prevents the usage of any of the medications in the study.
- Exclusion Criteria:
- • History of cervical surgery or presence of cervical scarring.
About Ain Shams Maternity Hospital
Ain Shams Maternity Hospital is a leading healthcare institution dedicated to providing comprehensive maternal and neonatal care. With a commitment to advancing women's health, the hospital engages in innovative clinical research and trials aimed at improving treatment outcomes and enhancing patient care. Equipped with state-of-the-art facilities and a team of experienced healthcare professionals, Ain Shams Maternity Hospital fosters a collaborative environment for research that prioritizes safety, efficacy, and ethical standards. Through its clinical trials, the hospital seeks to contribute to the global body of knowledge in obstetrics and gynecology, ultimately benefiting patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Salma Nassar, MD
Study Director
Ainshams maternity hospital
Ayman Abo nour, Prof
Principal Investigator
Ainshams maternity hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials